admin Posted on 3:24 pm

Key FDA official, CBD task force leader Amy Abernethy resigns

The process for regulating CBD was dealt another setback Tuesday with the resignation of Dr. Amy Abernethy from the U.S. Food and Drug Administration, who will leave the agency in mid- to late-April according to a memo from acting FDA Commissioner Janet Woodcock.
Key FDA official, CBD task force leader Amy Abernethy resigns is a post from: Hemp Industry Daily: Financial, Legal & business news for hemp & CBD entrepreneurs

Leave a Reply

Your email address will not be published. Required fields are marked *